Case Study: Boehringer Ingelheim optimizes FX hedging and reduces costs with Nomentia Risk Management

Boehringer Ingelheim - Customer Case Study

Boehringer Ingelheim, one of the largest research-based pharmaceutical companies in Germany, was professionally managing currency risk but faced challenges with system breaks between its SAP treasury system, a self-developed Excel tool, and Nomentia's liquidity forecasting. This disjointed process made it difficult to incorporate hedging costs as a decision criterion, creating inefficiencies and a susceptibility to errors in their risk management approach.

Nomentia implemented its Risk Management solution to fully automate and integrate the process. The solution connected directly with SAP to pull in hedging transactions and market data, and it leveraged the group-wide liquidity forecast from Nomentia's own platform to calculate cash flow at risk. This allowed Boehringer Ingelheim to eliminate manual work, greatly reduce errors, and use Nomentia's optimization function to execute a cost-optimal hedging strategy. The result was significantly reduced effort, full transparency, and lower hedging costs for the treasury team.

Boehringer Ingelheim

Jochen Alt

Senior Manager Corporate Treasury